Ruthenium(II)-p-cymene complexes featuring N-substituted N,S,S-donor ligands: Synthesis, stability, DNA-binding, and comparative in vitro cytotoxicity

This publication has 40 references indexed in Scilit:

• 6-Shogaol enhances the chemotherapeutic efficacy of 5-fluorouracil through apoptosis induction and cell cycle arrest in MCF-7 breast cancer cells
  Pharmacological Research - Modern Chinese Medicine, 2026
• Ruthenium compounds: Are they the next‐era anticancer agents?
  Applied Organometallic Chemistry, 2024
• Piano stool Ru(II)-arene complexes having three monodentate legs: A comprehensive review on their development as anticancer therapeutics over the past decade
  Coordination Chemistry Reviews, 2022
• Approaching tumour therapy beyond platinum drugs
  Journal of Inorganic Biochemistry, 2012
• Kinetics and mechanism of the reactions of Ru(II)–arene complex with some biologically relevant ligands
  Polyhedron, 2011
• Organometallic ruthenium-based antitumor compounds with novel modes of action
  Journal of Organometallic Chemistry, 2011
• DNA interactions of dinuclear RuII arene antitumor complexes in cell-free media
  Biochemical Pharmacology, 2009
• Classical and Non‐Classical Ruthenium‐Based Anticancer Drugs: Towards Targeted Chemotherapy
  European Journal of Inorganic Chemistry, 2006
• Ruthenium metallopharmaceuticals
  Coordination Chemistry Reviews, 2003
• Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1
  Advanced Drug Delivery Reviews, 2001